KRAS and cancer: Other significantly enriched pathways (FDR q-value < 0.05) were “hypoxia”, “KRAS signaling”, “myogenesis”, “angiogenesis”, and “apical junction”, supporting the hypothesis that PXN is related to the metastatic ability of cancer cells (Figure 7 and Table S2).